CHINA FEIHE (06186) has officially entered into a strategic cooperation agreement with Cpt. The collaboration focuses on deep integration in the supply of dairy protein raw materials, joint product research and development, and technological innovation. By leveraging their complementary industrial strengths, the two companies aim to create high-quality sports nutrition products and jointly explore new opportunities in China's premium dairy protein and sports nutrition markets.
The partnership between Feihe and Cpt comes at a time when global demand for high-quality protein is surging, driven by the advancing Healthy China strategy. The global markets for casein and whey protein are projected to reach $49.8 billion and $22 billion respectively by 2030, indicating significant growth potential. Concurrently, there is a notable gap in high-quality protein intake among the Chinese population, with increasing demand from athletes, fitness enthusiasts, and rehabilitation groups for highly active, absorbable, and pure dairy proteins.
Against this backdrop, Feihe and Cpt have strategically aligned to capture market opportunities. Their cooperation model combines proprietary raw material research, functional innovation, and channel synergy to address the nutritional health needs of the population across all life stages. Feihe brings its full-industry-chain dairy source advantages and leading capabilities in deep processing of dairy proteins, enabling stable supply of high-activity, high-value-added premium dairy protein raw materials, thus solidifying the industrial foundation for the partnership. Cpt, as a leading brand in China's sports nutrition sector, possesses deep expertise in product formulation R&D, channel networks, and consumer operations, along with strong capabilities in product transformation and market implementation.
The collaboration is guided by the principles of complementary strengths, joint creation, quality priority, and long-term mutual benefit. Both parties aim to jointly develop fast-growing sectors such as sports nutrition, creating high-quality functional nutrition products that better meet the needs of Chinese consumers.
With decades of dedicated research and industrial development in dairy proteins, Feihe has established a comprehensive system from technological breakthroughs to large-scale proprietary production. Supported by national research projects, Feihe has pioneered direct fresh milk extraction technology, moving away from the traditional "cheese-first, protein-later" method. Utilizing proprietary processes such as nanoscale biological membrane chromatography, low-temperature physical separation, and targeted enzymatic hydrolysis, the company maximizes the retention of proteins' natural activity.
Feihe has established deep-processing production lines for lactoferrin, casein, and small-molecule hydrolyzed milk protein, achieving 100% self-production capability for 11 key dairy raw materials. The company operates three major dairy protein raw material bases in Heilongjiang, Inner Mongolia, and Ningxia, with a daily fresh milk processing capacity exceeding 3,000 tons, ensuring global-scale supply capabilities.
Furthermore, Feihe collaborates with over 40 top-tier research institutions across seven countries to build an industry-academia-research innovation network. This robust R&D foundation and full-industry-chain control provide stable, high-quality, and highly active dairy protein assurance for the partnership.
Moving forward, both companies will steadily advance cooperative projects, deepen technological synergy and product innovation, and transform Feihe's premium dairy protein resources into functional nutrition products that better align with national needs. This collaboration aims to promote the upgrade of China's dairy industry towards higher value-added products, safeguarding public health with high-quality protein nutrition.
Comments